Todd Whitson

Todd Whitson has over 24 years of experience in the healthcare industry. Todd began their career in 1997 as a District Sales Manager at Eli Lilly & Company. In 2006, they moved to Novartis as a Regional Manager. In 2008, they became the VP of Sales at Genzyme Genetics (acquired by LabCorp). In 2011, they became the VP of Sales and Commercial Operations at Ariosa Diagnostics (acquired by Roche). In 2016, they were appointed Chief Commercial Officer at CareDx, Inc. In 2017, they became the Chief Commercial Officer at Karius, Inc. In 2018, they took on the role of Strategic Advisor at CellMax Life. In 2019, they became the Chief Strategy Officer at Nephrosant, Inc. Currently, they serve as the EVP, Global Business Development and Commercial Operations at Juno Diagnostics.

Todd Whitson attended Lafayette College from 1991 to 1993, where they earned a Bachelor of Arts in Economics/Psychology. Todd then attended University of Richmond from 1994 to 1996, where they earned a Master of Science in Sports Administration.